International Journal of Hematology

, Volume 75, Issue 4, pp 388–393 | Cite as

cDNA Microarray Analysis of Chronic Myeloid Leukemia

  • Huiyu Li
  • Shenghua Jie
  • Ping Zou
  • Guolin Zou
Review Article


A series of expression microarray analyses of chronic myeloid leukemia (CML) by means of complementary DNA microarray representing a set of 1024 human genes were initiated to evaluate the role of expression microarray analysis in CML and to identify CML-associated genes.Among the target genes, 388 differentially expressed genes were identified. In 2 cases the expression level of 74 to 91 genes and in 3 cases that of 45 genes differed between the normal control and CML cells. Results of analysis of messenger RNA profiles indicated that 19 of 45 differentially expressed genes were up-regulated whereas others were down-regulated. The expression profile included oncogenes, tumor suppression genes, and human genes encoding proteins involved in the functions of transcription, signal transduction, metabolism, cell growth, differentiation, and apoptosis. The function of the immune system also was observed. Identification of these genes allows a quantitative view of the changes that accompany CML at the genomic level and enables deeper insights into the molecular basis of the disease.

Key words

cDNA microarray Gene expression pattern Chronic myeloid leukemia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Daley GQ,Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by P210bcr-abl gene of the Philadelphia chromosome.Science. 1990;247:824–834.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Shalon D, Smith SJ, Brown PO. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization.Genome Res. 1996;6:639–645.CrossRefPubMedGoogle Scholar
  3. 3.
    DeRisi JL, Iyer VR, Brown PO. Exploring the metabolic and genetic control of gene expression on a genomic scale.Science. 1997;278:680–686.CrossRefPubMedGoogle Scholar
  4. 4.
    Schena M, Shalon D, Heller R, Chai A, Brown PO, Davis RW. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes.Proc Natl Acad Sci U S A. 1996;93: 10614–10619.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Louis D, Gusella J. Antigen behind many doors: multiple genetic pathway to malignant glioma trends.Gene. 1995;11:412–415.Google Scholar
  6. 6.
    Smith LM, Birrer MJ, Stampfer MR, Brown PH. Breast cancer cells have lower activating protein 1 transcription factor activity than normal mammary epithelial cells.Cancer. 1997;57:3046–3054.Google Scholar
  7. 7.
    Wang K, Gan L, Jeffery E, et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray.Gene. 1999;229:101–108.CrossRefPubMedGoogle Scholar
  8. 8.
    Iwabuchi K, Li B, Massa HF, Trask BJ, Date T, Fields S. Stimulation by the P53-mediated transcriptional activation by the P53-binding proteins, 53BP1 and 53BP2.Biol Chem. 1998;273:26061–26068.CrossRefGoogle Scholar
  9. 9.
    Koken MH, Reynolds P, Jaspers-Dekker I, et al. Structural and functional conservation of two human homologs of the yeast DNA repair gene RAD6.Proc Natl Acad Sci U S A. 1991;88:8865–8869.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kordes U, Krappmann D, Heissmeyer V, Ludwig WP, Scheidereit C. Transcription factor NF-kappaB is constitutively activated in acute lymphoblastic leukemia.Leukemia. 2000;4:399–402.CrossRefGoogle Scholar
  11. 11.
    Reuther JY, Reuther GW, Cortez D, Pendergast AM, Baldwin AS Jr.A requirement for NF-kB activation in Bcr-Abl-mediated transformation.Genes Dev. 1998;12:968–981.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Lania L, Donti E, Pannuti A, et al. cDNA isolation, expression analysis and chromosomal localization of two human zinc finger genes.Genomics. 1990;6:333–340.CrossRefPubMedGoogle Scholar
  13. 13.
    Druker B, Okuda K, Matulonis U, Salgia R, Roberts T, Griffin JD. Tyrosine phosphorylation of ras GAP and associated proteins in chronic myelogenous leukemia cell lines.Blood. 1992;79: 2215–2220.PubMedGoogle Scholar
  14. 14.
    Pendergast AM, Quilliam LA, Cripe LD. et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adapter protein.Cell. 1993;75:175–185.CrossRefPubMedGoogle Scholar
  15. 15.
    Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.Cell. 1997;91:231–241.CrossRefPubMedGoogle Scholar
  16. 16.
    Kapeller R, Cantley LC. Phosphatidylinositol 3-kinase.Bioessays. 1994;16:565–564.CrossRefPubMedGoogle Scholar
  17. 17.
    Bhatia R, Verfaillie CM. Inhibition of BCR-ABL expression with antisense oligodeoxynucleotides restores β 1 integrin-mediated adhesion and proliferation inhibition in chronic myelogenous leukemia hematopoietic progenitors.Blood. 1998;91:3414–3422.PubMedGoogle Scholar
  18. 18.
    Kumerpva A, Lece A, Skesters A, Silova A, Petuhovs V. Anaemia and antioxidant defence of red blood cells.Mater Med Pol. 1998;30:12–15.Google Scholar
  19. 19.
    Wang CM, Chen XS, Li MS, et al. The study on the activities of SOD R GSH-PX in leukemia cell.Chin J Exp Hematol. 1996;20:304–308.Google Scholar

Copyright information

© The Japanese Society of Hematology 2002

Authors and Affiliations

  1. 1.Union Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanP.R. China
  2. 2.College of Life ScienceWuhan UniversityWuhanP.R. China

Personalised recommendations